Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HTR1D | P28221 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14707718 | 1.00 | KIF11 (0.56) | KIF11TSHRLMNATYRXDH | |
| SCHEMBL67741 | 0.92 | TSHR (0.55) | KIF11TSHRLMNATYRNPC1 | |
| Iodide SCHEMBL217484 | 0.89 | TSHR (0.52) | KIF11TSHRLMNATYRNPC1 | |
| SCHEMBL6516058 | 0.89 | TSHR (0.52) | KIF11TSHRLMNATYRNPC1 | |
| SCHEMBL6524730 | 0.89 | TSHR (0.52) | KIF11TSHRLMNATYRNPC1 | |
| SCHEMBL18017084 | 0.87 | KIF11 (0.50) | KIF11TSHRLMNATYRXDH | |
| SCHEMBL17428518 | 0.87 | KIF11 (0.50) | KIF11TSHRLMNATYRXDH | |
| SCHEMBL26915 | 0.86 | KIF11 (0.70) | KIF11TSHRLMNATYRXDH | |
| SCHEMBL3423876 | 0.86 | KIF11 (0.70) | KIF11TSHRLMNATYRXDH | |
| SCHEMBL16787954 | 0.84 | TSHR (0.48) | KIF11TSHRLMNATYRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-21 | — | — | US | disclosed |
| CN-116710846-A | Photosensitive resin composition, photosensitive resin coating film, photosensitive dry film, and pattern forming method | 信越化学工业株式会社 | 2023-09-05 | — | — | CN | disclosed |
| US-7270857-B2 | Liquid crystal composition and liquid crystal element | FUJIFILM CORPORATION (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7270857-B2 | Liquid crystal composition and liquid crystal element | FUJIFILM CORPORATION (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7270857-B2 | Liquid crystal composition and liquid crystal element | FUJIFILM CORPORATION (JP) | 2007-09-18 | — | — | US | disclosed |
| US-7220465-B2 | Liquid crystal composition, anthraquinone compound and liquid crystal device employing the composition | FUJIFILM CORPORATION (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220465-B2 | Liquid crystal composition, anthraquinone compound and liquid crystal device employing the composition | FUJIFILM CORPORATION (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220465-B2 | Liquid crystal composition, anthraquinone compound and liquid crystal device employing the composition | FUJIFILM CORPORATION (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20050173673-A1 | Liquid crystal composition, anthraquinone compound and liquid crystal device employing the composition | FUJI PHOTO FILM CO., LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| US-20050072962-A1 | Liquid crystal composition and liquid crystal element | FUJI PHOTO FILM CO., LTD. (JP) | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301182-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, ESR1, EPCAM | KIF11 2629/4885TSHR 4575/4885LMNA 3840/4885 |
| US-20050072962-A1 | Liquid crystal composition and liquid crystal element | CXCR1, CXCR2, LRRK2 | KIF11 1916/4885TSHR 2047/4885LMNA 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.